The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
1,500 jobs Number of planned job losses
Announcement Date
1 March 2007
Employment effect (start)
30 June 2008
Foreseen end date
Description
In June 2006 the Schering AG and the pharmaceutical division of Bayer's subsidiary Bayer HealthCare were merged into Bayer Schering Pharma AG, a manufacturer of pharmaceutical products. On 1 March 2007, Bayer Schering announced details of its restructuring scheme following the merger. The company stated in a press release that starting from 2009, it will seek to save 700 million Euro per year (800 million Euro according to a June 2007 press release) following synergies from the merger. As a result of this, 6,100 jobs will be cut worldwide: 3,150 in Europe, 1,000 in the USA, 750 in Asia-Pacific region and Japan and 1,200 in Latin America and Canada. 1,500 jobs will be cut in Germany. According to a June 2007 press release, the research and development divisions will be strongly affected by the job cuts. All in all, 20 research projects will be terminated.
In Germany 950 jobs will be lost at the company's headquarter in Berlin, where the company currently employs 6,000 people. There is no information available on the remaining 550 job cuts in Germany. Regarding the 950 jobs to be lost in Berlin, 350 employees have already accepted individual solutions, such as retirement schemes or cancellation agreements including compensation payments. Another 250 employees will be offered different positions in the Bayer group. The company stated that there will be no direct dismissals until mid 2008 in Berlin. Bayer Pharma Schering currently employs around 40,000 people worldwide.
Sources
20 June 2007: Financial Times Deutschland
1 March 2007: Handelsblatt
Citation
Eurofound (2007), Bayer Schering Pharma AG, Merger/Acquisition in Germany, factsheet number 65029, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/65029.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...